SUPN·868459108·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
SUPN (SUPERNUS PHARMACEUTICALS) is held by 153 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($454.7M), MILLENNIUM MANAGEMENT LLC ($171.4M), DIMENSIONAL FUND ADVISORS LP ($119.2M). Net institutional sentiment: Mixed.
See how SUPN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer